Tandem Diabetes Care share price today
(NASDAQ: TNDM)

Name: Tandem Diabetes Care Share Price Today (NASDAQ: TNDM) - Tandem Diabetes Care Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Tandem Diabetes Care share price is $35.5 & ₹3,070.40 as on 24 Jan 2025, 2.30 'hrs' IST

$35.5

▲

0.5

(1.43%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Tandem Diabetes Care share price in Dollar and Rupees. Guide to invest in Tandem Diabetes Care stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tandem Diabetes Care, along with analyst recommendations, forecasts, and comprehensive financials.

Tandem Diabetes Care share price movements

Today's Low: $34.44
Today's High: $35.50
$35.50
3.0%
Downside
Day's Volatility :3.0%
Upside
0.0%
52 Weeks Low: $21.85
52 Weeks High: $53.69
$35.50
38.45%
Downside
52 Weeks Volatility :59.3%
Upside
33.88%

Tandem Diabetes Care Returns

Period	Tandem Diabetes Care, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	11.64%	-5.5%	0.0%
6 Months	-12.61%	-4.3%	0.0%
1 Year	52.24%	1.6%	0.0%
3 Years	-70.11%	9.8%	-11.0%

Tandem Diabetes Care Key Statistics

in dollars & INR

Previous Close	$35.0
Open	$34.75
Today's High	$35.49
Today's Low	$34.435
Market Capitalization	$2.3B
Today's Volume	$908.2K
52 Week High	$53.69
52 Week Low	$21.85
Revenue TTM	$854.4M
EBITDA	$-130.7M
Earnings Per Share (EPS)	$-1.94
Profit Margin	-14.84%
Quarterly Earnings Growth YOY	-0.37%
Return On Equity TTM	-45.96%

How to invest in Tandem Diabetes Care Stock (TNDM) from India?

It is very easy for Indian residents to invest directly in Tandem Diabetes Care from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tandem Diabetes Care stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tandem Diabetes Care or TNDM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tandem Diabetes Care or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tandem Diabetes Care shares which would translate to 0.024 fractional shares of Tandem Diabetes Care as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tandem Diabetes Care, in just a few clicks!

Returns in Tandem Diabetes Care for Indian investors in Rupees

Investment Value

₹1,00,000

Tandem Diabetes Care investment value today

Current value as on today

₹1,58,469

Returns

₹58,469

(+58.47%)

Returns from Tandem Diabetes Care Stock

₹54,415 (+54.41%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Tandem Diabetes Care

-57%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Tandem Diabetes Care on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -57% less investors are searching Tandem Diabetes Care in the last 30 days versus the previous period.

Global Institutional Holdings in Tandem Diabetes Care

BlackRock Inc
16.92%
Vanguard Group Inc
11.21%
Capital World Investors
4.97%
State Street Corp
4.04%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
3.63%
Fred Alger Management, LLC
3.01%

Analyst Recommendation on Tandem Diabetes Care

Buy

65%Buy

30%Hold

4%Sell

Based on 23 Wall street analysts offering stock ratings for Tandem Diabetes Care(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Tandem Diabetes Care

What analysts predicted

Upside of 43.94%

Target:

$51.10

Current:

$35.50

Insights on Tandem Diabetes Care

Price Movement
In the last 7 days, TNDM stock has moved down by -6.7%
Increasing Revenue
Revenue is up for the last 3 quarters, 191.67M → 363.28M (in $), with an average increase of 26.3% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -42.71M → -23.25M (in $), with an average increase of 35.6% per quarter
TNDM vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 65.5% return, outperforming this stock by 11.3%
TNDM vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 133.4% return, outperforming this stock by 205.0%
Price to Sales
ForTNDM every $1 of sales, investors are willing to pay $2.7, whereas for Boston Scientific Corp., the investors are paying $9.3 for every $1 of sales.

Tandem Diabetes Care Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$183.9M	↑ 70.88%
Net Income	$-122.6M	↑ 67.88%
Net Profit Margin	-66.68%	↑ 1.19%

	FY19	Y/Y Change
Revenue	$362.3M	↑ 97.05%
Net Income	$-24.8M	↓ 79.81%
Net Profit Margin	-6.83%	↑ 59.85%

	FY20	Y/Y Change
Revenue	$498.8M	↑ 37.68%
Net Income	$-34.4M	↑ 38.9%
Net Profit Margin	-6.89%	↓ 0.06%

	FY21	Y/Y Change
Revenue	$702.8M	↑ 40.89%
Net Income	$15.6M	↓ 145.27%
Net Profit Margin	2.21%	↑ 9.1%

	FY22	Y/Y Change
Revenue	$801.2M	↑ 14.0%
Net Income	$-94.6M	↓ 707.7%
Net Profit Margin	-11.81%	↓ 14.02%

	FY23	Y/Y Change
Revenue	$747.7M	↓ 6.68%
Net Income	$-222.6M	↑ 135.33%
Net Profit Margin	-29.77%	↓ 17.96%

	Q2 FY23	Q/Q Change
Revenue	$195.9M	↑ 15.67%
Net Income	$-35.8M	↓ 71.12%
Net Profit Margin	-18.26%	↑ 54.87%

	Q3 FY23	Q/Q Change
Revenue	$185.6M	↓ 5.25%
Net Income	$-33.0M	↓ 7.87%
Net Profit Margin	-17.76%	↑ 0.5%

	Q4 FY23	Q/Q Change
Revenue	$196.8M	↑ 6.02%
Net Income	$-30.0M	↓ 8.98%
Net Profit Margin	-15.25%	↑ 2.51%

	Q1 FY24	Q/Q Change
Revenue	$191.7M	↓ 2.6%
Net Income	$-42.7M	↑ 42.37%
Net Profit Margin	-22.29%	↓ 7.04%

	Q2 FY24	Q/Q Change
Revenue	$221.9M	↑ 15.77%
Net Income	$-30.8M	↓ 27.86%
Net Profit Margin	-13.89%	↑ 8.4%

	Q3 FY24	Q/Q Change
Revenue	$363.3M	↑ 63.71%
Net Income	$-23.3M	↓ 24.54%
Net Profit Margin	-6.4%	↑ 7.49%

	FY18	Y/Y Change
Profit	$89.8M	↑ 103.71%

	FY19	Y/Y Change
Profit	$194.2M	↑ 116.22%

	FY20	Y/Y Change
Profit	$260.5M	↑ 34.14%

	FY21	Y/Y Change
Profit	$376.2M	↑ 44.41%

	FY22	Y/Y Change
Profit	$413.0M	↑ 9.77%

	FY23	Y/Y Change
Profit	$367.7M	↓ 10.97%

	Q2 FY23	Q/Q Change
Profit	$101.7M	↑ 22.71%

	Q3 FY23	Q/Q Change
Profit	$89.8M	↓ 11.78%

	Q4 FY23	Q/Q Change
Profit	$93.3M	↑ 3.95%

	Q1 FY24	Q/Q Change
Profit	$94.7M	↑ 1.48%

	Q2 FY24	Q/Q Change
Profit	$112.8M	↑ 19.14%

	Q3 FY24	Q/Q Change
Profit	$124.7M	↑ 10.51%

	FY18	Y/Y Change
Operating Cash Flow	$-8.3M	↓ 87.42%
Investing Cash Flow	$-90.7M	↓ 3361.65%
Financing Cash Flow	$117.2M	↑ 261.95%

	FY19	Y/Y Change
Operating Cash Flow	$41.9M	↓ 603.73%
Investing Cash Flow	$-57.0M	↓ 37.23%
Financing Cash Flow	$24.2M	↓ 79.34%

	FY20	Y/Y Change
Operating Cash Flow	$24.7M	↓ 41.13%
Investing Cash Flow	$-296.1M	↑ 419.81%
Financing Cash Flow	$314.4M	↑ 1198.95%

	FY21	Y/Y Change
Operating Cash Flow	$111.4M	↑ 351.41%
Investing Cash Flow	$-186.9M	↓ 36.88%
Financing Cash Flow	$51.9M	↓ 83.48%

	FY22	Y/Y Change
Operating Cash Flow	$50.5M	↓ 54.68%
Investing Cash Flow	$33.2M	↓ 117.75%
Financing Cash Flow	$16.9M	↓ 67.5%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-6.3M	↓ 65.5%
Investing Cash Flow	$5.7M	↓ 121.64%
Financing Cash Flow	$3.9M	↓ 829.76%

Tandem Diabetes Care Technicals Summary

Sell

Neutral

Buy

Tandem Diabetes Care is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Tandem Diabetes Care Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tandem Diabetes Care, Inc.	-6.34%	-12.61%	52.24%	-70.11%	-49.16%
Medtronic Plc	7.73%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-8.41%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	10.15%	33.89%	64.9%	135.97%	135.19%
Stryker Corporation	5.32%	17.73%	25.19%	56.65%	81.96%
Abbott Laboratories	2.63%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tandem Diabetes Care, Inc.	473.44	NA	0.0	-1.72	-0.46	-0.1	NA	3.62
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tandem Diabetes Care, Inc.	Buy	$2.3B	-49.16%	473.44	-14.84%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

About Tandem Diabetes Care

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Organization	Tandem Diabetes Care
Employees	2400
CEO	Mr. John F. Sheridan
Industry	Health Technology

Management People of Tandem Diabetes Care

Name	Title
Mr. John F. Sheridan	President, CEO & Director
Ms. Leigh A. Vosseller	Executive VP, CFO & Treasurer
Ms. Susan M. Morrison	Executive VP & Chief Administrative Officer
Ms. Elizabeth Anne Gasser	Executive Vice President and Chief Strategy & Product Officer
Mr. Mark Novara	Executive VP & Chief Commercial Officer
Mr. Jean-Claude E. Kyrillos	Executive VP & COO
Mr. Rick A. Carpenter	Chief Technical Officer
Ms. Shannon M. Hansen J.D.	Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary
Mr. Tom Fox	Chief Human Resources Officer
Dr. Jordan Pinsker M.D.	Chief Medical Officer

Important FAQs about investing in Tandem Diabetes Care (TNDM) from India :

What is Tandem Diabetes Care share price today?

Tandem Diabetes Care share price today stands at $35.50, Open: $34.75 ; Previous Close: $35.00 ; High: $35.50 ; Low: $34.44 ; 52 Week High: $53.69 ; 52 Week Low: $21.85. The stock opens at $34.75, after a previous close of $35.00. The stock reached a daily high of $35.50 and a low of $34.44, with a 52-week high of $53.69 and a 52-week low of $21.85.

Can Indians buy Tandem Diabetes Care shares?

Yes, Indians can invest in the Tandem Diabetes Care (TNDM) from India.

With INDmoney, you can buy Tandem Diabetes Care at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Tandem Diabetes Care at zero transaction cost.

How can I buy Tandem Diabetes Care shares from India?

It is very easy to buy Tandem Diabetes Care from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tandem Diabetes Care be purchased?

Yes, you can buy fractional shares of Tandem Diabetes Care with INDmoney app.

What are the documents required to start investing in Tandem Diabetes Care stocks?

To start investing in Tandem Diabetes Care, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.